HER2 testing in patients with breast cancer

BMJ. 2012 Jun 11:344:e3958. doi: 10.1136/bmj.e3958.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Ado-Trastuzumab Emtansine
  • Antibodies, Monoclonal, Humanized / administration & dosage
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / metabolism*
  • Breast Neoplasms / surgery
  • Chemotherapy, Adjuvant
  • Docetaxel
  • Female
  • Humans
  • Immunohistochemistry
  • Lapatinib
  • Maytansine / analogs & derivatives
  • Maytansine / therapeutic use
  • Neoadjuvant Therapy
  • Quinazolines / administration & dosage
  • Receptor, ErbB-2 / metabolism*
  • Taxoids / administration & dosage
  • Trastuzumab

Substances

  • Antibodies, Monoclonal, Humanized
  • Quinazolines
  • Taxoids
  • Lapatinib
  • Maytansine
  • Docetaxel
  • Receptor, ErbB-2
  • pertuzumab
  • Trastuzumab
  • Ado-Trastuzumab Emtansine